Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Zaire ebolavirus NP/Nucleoprotein Protein, C-His

Catalog #:   YVV22701 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: AXF48955.1
Protein length: Val36-Glu351
Overview

Catalog No.

YVV22701

Expression system

E. coli

Species

Zaire ebolavirus

Protein length

Val36-Glu351

Predicted molecular weight

36.18 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

AXF48955.1

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Nucleoprotein, Nucleocapsid protein, NP

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Zaire ebolavirus NP/Nucleoprotein Protein
References

Development of a Pentacistronic Ebola Virus Minigenome System., PMID:40431699

Structural basis for Ebola virus nucleocapsid assembly and function regulated by VP24., PMID:40064872

Ebola and Marburg viruses IgG detections in small ruminants and dogs from villages within outbreak areas in Gabon., PMID:40043032

Computational study of interaction of calixarene with ebola virus structural proteins and its potential therapeutic implications., PMID:39961277

To be or not to be phosphorylated: understanding the role of Ebola virus nucleoprotein in the dynamic interplay with the transcriptional activator VP30 and the host phosphatase PP2A-B56., PMID:39726359

Ginkgolic acid inhibits Ebola virus transcription and replication by disrupting the interaction between nucleoprotein and VP30 protein., PMID:39716669

Intracellular Ebola virus nucleocapsid assembly revealed by in situ cryo-electron tomography., PMID:39293445

Impact of Ebola virus nucleoprotein on VP40 virus-like particle production: a computational approach., PMID:38796621

Serological evidence of zoonotic filovirus exposure among bushmeat hunters in Guinea., PMID:38755147

ICTV Virus Taxonomy Profile: Filoviridae 2024., PMID:38305775

Molecular modeling and simulation studies of SELEX-derived high-affinity DNA aptamers to the Ebola virus nucleoprotein., PMID:38217874

Extracellular vesicle storm during the course of Ebola virus infection in primates., PMID:38035334

Structural insights on the nucleoprotein C-terminal domain of Měnglà virus., PMID:37888996

Disruption of Ebola NP0VP35 Inclusion Body-like Structures reduce Viral Infection., PMID:37598728

The 3' Untranslated Regions of Ebola Virus mRNAs Contain AU-Rich Elements Involved in Posttranscriptional Stabilization and Decay., PMID:37551415

Ebola virus inclusion bodies are liquid organelles whose formation is facilitated by nucleoprotein oligomerization., PMID:37306660

Diagnostics of Ebola virus., PMID:36908455

Inhibiting the transcription and replication of Ebola viruses by disrupting the nucleoprotein and VP30 protein interaction with small molecules., PMID:36759643

Cellular and humoral immunity to Ebola Zaire glycoprotein and viral vector proteins following immunization with recombinant vesicular stomatitis virus-based Ebola vaccine (rVSVΔG-ZEBOV-GP)., PMID:36725433

Ebola Virus Activates IRE1α-Dependent XBP1u Splicing., PMID:36680162

Randomized Trial of Vaccines for Zaire Ebola Virus Disease., PMID:36516078

Self-amplifying RNA vaccine protects mice against lethal Ebola virus infection., PMID:36303436

Filovirus helical nucleocapsid structures., PMID:36242583

Evidence for Viral mRNA Export from Ebola Virus Inclusion Bodies by the Nuclear RNA Export Factor NXF1., PMID:36040180

Role of VP30 Phosphorylation in Ebola Virus Nucleocapsid Assembly and Transport., PMID:35993739

Detection of filovirus-reactive antibodies in Australian bat species., PMID:35972225

Ebola-Detect: A differential serodiagnostic assay for Ebola virus infections and surveillance in the presence of vaccine-induced antibodies., PMID:35901660

Assembly and transport of filovirus nucleocapsids., PMID:35900983

Structural insights into the interactions between lloviu virus VP30 and nucleoprotein., PMID:35649303

Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER region., PMID:35584193

Designing a novel multi‑epitope vaccine against Ebola virus using reverse vaccinology approach., PMID:35545650

TRIM25 and ZAP target the Ebola virus ribonucleoprotein complex to mediate interferon-induced restriction., PMID:35533151

One-step single-tube accelerated quantitative nucleoprotein gene-specific reverse transcription loop-mediated isothermal gene amplification (RT-LAMP) assay for rapid, real-time & reliable clinical detection of Ebola virus., PMID:35435345

Structural insight into Marburg virus nucleoprotein-RNA complex formation., PMID:35246537

Visualizing Filoviral Nucleoproteins Using Nanobodies Fused to the Ascorbate Peroxidase Derivatives APEX2 and dEAPX., PMID:35157287

Ebola Virus GP Activates Endothelial Cells via Host Cytoskeletal Signaling Factors., PMID:35062347

Generating Uniformly Cross-Reactive Ebolavirus spp. Anti-nucleoprotein Nanobodies to Facilitate Forward Capable Detection Strategies., PMID:34994194

Functional Importance of Hydrophobic Patches on the Ebola Virus VP35 IFN-Inhibitory Domain., PMID:34835122

Structural and Functional Aspects of Ebola Virus Proteins., PMID:34684279

A computational overview on phylogenetic characterization, pathogenic mutations, and drug targets for Ebola virus disease., PMID:34563987

Marburg and Ebola Virus mRNA 3' Untranslated Regions Contain Negative Regulators of Translation That Are Modulated by ADAR1 Editing., PMID:34346762

Development of a New Reverse Genetics System for Ebola Virus., PMID:33952663

A paramyxovirus-like model for Ebola virus bipartite promoters., PMID:33152032

The two-stage interaction of Ebola virus VP40 with nucleoprotein results in a switch from viral RNA synthesis to virion assembly/budding., PMID:33141416

Characteristics of Ebola Virus Disease Survivor Blood and Semen in Liberia: Serology and Reverse Transcription Polymerase Chain Reaction (RT-PCR)., PMID:32894277

Comparison of Zaire ebolavirus realtime RT-PCRs targeting the nucleoprotein gene., PMID:32707049

Identification of interferon-stimulated genes that attenuate Ebola virus infection., PMID:32528005

Ebola Virus Inclusion Body Formation and RNA Synthesis Are Controlled by a Novel Domain of Nucleoprotein Interacting with VP35., PMID:32493824

Large-scale mapping of the Ebola NP and GP proteins reveals multiple immunoprevalent and conserved CD4 T-cell epitopes., PMID:32398806

The Cellular Protein CAD is Recruited into Ebola Virus Inclusion Bodies by the Nucleoprotein NP to Facilitate Genome Replication and Transcription., PMID:32370067

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Zaire ebolavirus NP/Nucleoprotein Protein, C-His [YVV22701]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only